Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G N Bisaga

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 7, 2002
[New approaches to antioxidant therapy in multiple sclerosis]M M Odinak, G N Bisaga, I V Zarubina
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 14, 2012
[Diagnosis and differential diagnosis of demyelinating optic neuropathy in multiple sclerosis]G N Bisaga, A V Kovalenko, I Iu Kovalenko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 22, 2017
[Intravenous immunoglobulins: perspectives in multiple sclerosis (a literature review with own results)]G N Bisaga, I D Skulyabin, A E Popov
Bulletin of Experimental Biology and Medicine|February 15, 2001
Morphological changes in the skin during experimental allergic encephalomyelitis and multiple sclerosis: bases for new diagnostic testG N Bisaga, L S Onishchenko, L N Adel'son
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 16, 2019
[Progress and prospects of metabolic therapy in multiple sclerosis]G N Bisaga, A A Mikhailenko, I N Barsukov
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 9, 2001
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis]A V Pozdniakov, L A Tiutin, G N Bisaga, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 1, 1992
[Role of specific brain peptide factors in the pathogenesis and compensation of neurologic disorders and their use in the treatment of nervous system diseases]G A Vartanian, M V Neuĭmina, V I Golovkin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 1, 1996
[Modern diagnostic methods in multiple sclerosis]G N Bisaga, V I Golovkin, S A Lytaev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 20, 2021
[Difficulties of cerebral toxoplasmosis diagnosis in a patient with multiple sclerosis and HIV]M P Topuzova, A D Chaykovskaya, G N Bisaga, et al.
Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova|February 5, 2016
[The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis]S V Murav'eva, G N Bisaga, S V Pronin, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 7, 2002
[New approaches to antioxidant therapy in multiple sclerosis]M M Odinak, G N Bisaga, I V Zarubina
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 14, 2012
[Diagnosis and differential diagnosis of demyelinating optic neuropathy in multiple sclerosis]G N Bisaga, A V Kovalenko, I Iu Kovalenko
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 22, 2017
[Intravenous immunoglobulins: perspectives in multiple sclerosis (a literature review with own results)]G N Bisaga, I D Skulyabin, A E Popov
Bulletin of Experimental Biology and Medicine|February 15, 2001
Morphological changes in the skin during experimental allergic encephalomyelitis and multiple sclerosis: bases for new diagnostic testG N Bisaga, L S Onishchenko, L N Adel'son
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 16, 2019
[Progress and prospects of metabolic therapy in multiple sclerosis]G N Bisaga, A A Mikhailenko, I N Barsukov
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 9, 2001
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis]A V Pozdniakov, L A Tiutin, G N Bisaga, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|January 1, 1992
[Role of specific brain peptide factors in the pathogenesis and compensation of neurologic disorders and their use in the treatment of nervous system diseases]G A Vartanian, M V Neuĭmina, V I Golovkin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 1, 1996
[Modern diagnostic methods in multiple sclerosis]G N Bisaga, V I Golovkin, S A Lytaev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|July 20, 2021
[Difficulties of cerebral toxoplasmosis diagnosis in a patient with multiple sclerosis and HIV]M P Topuzova, A D Chaykovskaya, G N Bisaga, et al.
Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova|February 5, 2016
[The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis]S V Murav'eva, G N Bisaga, S V Pronin, et al.
Pageof 3